HARBIN, China, Aug 12, 2011 /PRNewswire-Asia-FirstCall/ --
Financial Highlights for the Three Months Ended June 30, 2011:
Financial Highlights for the Six Months Ended June 30, 2011:
Nutrastar International Inc. (OTCBB: NUIN; "Nutrastar" or the "Company"), a leading producer and supplier of premium branded Traditional Chinese Medicine ("TCM") consumer products, today announced record financial results for the three and six months ended June 30, 2011.
Ms. Lianyun Han, CEO of Nutrastar, commented, "We are pleased to report another successful quarter for Nutrastar and its shareholders, characterized by marked increases in both top and bottom line growth and continued expansion of our functional health beverage product line. Revenue recorded increased roughly 40% compared to the same 2010 period, indicative of strong and steady consumer demand for our core product, commercially cultivated Cordyceps Militaris, and growing demand for our beverages. Launched late last year, beverage sales increased significantly, approximately 390%, reaching $1.13 million for the second quarter of 2011, as compared to $0.23 million recorded in the first quarter of 2011. Net income rose 14.2% in the second quarter when compared to the same period of 2010. Overall gross margin for the second quarter was 77.4%."
"On the sales and distribution front, we've made significant yet conservative strides in broadening our channels and expanding our presence in the consumer market. In June, we opened our second specialty product store in a highly populated district of Harbin, further increasing our brand awareness and product availability in that area. In May, we ramped up our beverage distribution in Anhui Province with the signing of a new major distributor, adding over 400 points-of-sale to our distribution network. We are currently in negotiations with additional distributors and anticipate signing with some of these distributors in the future to more effectively and strategically pursue our expansion initiatives. We are preparing to increase our marketing efforts to bring more attention and interest to our functional health drink product line, which will require some capital currently on the balance sheet. As for new products, our recently released entry-level drink "Yang Yang Ba" has seen healthy sales volume since its introduction into the market and we are eager to bring our new exciting, unique Cordyceps-infused alcohol product to the market in the near future."
"Looking ahead into the remainder of 2011, we expect to continue to steadily execute on our focused strategies of growing organically and diversifying our consumer product offerings. Within these initiatives, we'll remain active in further broadening our sales and distribution network and increasing our production capacity in order to better meet the demand of the current consumer market. Currently, we are on track to bring online 3 additional buildings located on our production facility grounds by the end of the year, resulting in a 20% increase in annual capacity for our core product, reaching approximately 87 tons going into 2012. Lastly, based on the current forecast we are comfortable with the revenue guidance given at the beginning of the year," concluded Ms. Han.
Financial Results for Three Months and Six Months Ended June 30, 2011:Revenue
Revenue generated from sales of Nutrastar products for the three months ended June 30, 2011 was $7.68 million, an increase of $2.23 million or 40.8% from $5.46 million for the same period in 2010. Revenue generated from sales of Nutrastar products for the six months ended June 30, 2011 was $13.48 million, an increase of $3.25 million or 31.8% from $10.23 million for the same period in 2010. This increase was mainly attributable to continued demand for our core product, commercially cultivated Cordyceps Militaris, and increased sales of our functional health beverage products, which were launched in the fourth quarter of 2010.
Revenue by Business Segment The Company's revenue is categorized into three segments based on our product portfolio. In the three months ended June 30, 2011, revenue from our commercially cultivated Cordyceps Militaris was $6.07 million, representing 79.0% of total revenue; revenue from our organic and specialty food products was $0.48 million, representing 6.3% of total revenue; and revenue from our newly introduced functional health beverage product line was $1.13 million, representing 14.7% of total revenue. In the six months ended June 30, 2011, revenue from our commercially cultivated Cordyceps Militaris was $11.15 million, comprising 82.7% of total revenue; revenue from our organic and specialty food products was $0.97 million, comprising 7.2% of total revenue; and revenue from our newly introduced functional health beverage product line was $1.36 million, comprising 10.1% of total revenue. The functional health beverage product line was introduced in mid-November 2010 and has been rolled out in select cities in Jiangsu and Anhui.
For the three months ended June 30, 2011, overall gross profit was $5.95 million, an increase of $1.38 million or 30.1% from $4.57 million during the same period in 2010. Gross margin was 77.4% for the three months ended June 30, 2011, a decrease of 7.5% from 83.7% in 2010. Overall gross profit was $10.37 million for the six months ended June 30, 2011, an increase of $2.09 million or 25.3% from $8.28 million during the same period in 2010. Gross margin was 77.0% for the six months ended June 30, 2011, a decrease of 4.9% from 81.0% in 2010. The decrease was mainly due to a change in product mix and the inclusion of our functional health beverages, which were not offered in the same period of 2010. Our functional health beverage products have a lower gross margin than our commercially cultivated Cordyceps Militaris.
Cost of Goods Sold
Cost of goods sold, comprising costs related to raw materials, labor and overhead, was $1.74 million for the three months ended June 30, 2011, an increase of $0.85 million, or 95.5% from $0.89 million in the prior period of 2010. Cost of goods sold for the six months ended June 30, 2011 was $3.11 million, an increase of $1.16 million or 59.7% from $1.95 million recorded in the same period of 2010. This increase was mainly a result of an increase in sales for our core product, commercially cultivated Cordyceps Militaris, and an increase in production costs associated with our functional health beverages product line, which did not exist in the same period of 2010. As a percentage of revenues, the cost of goods sold increased to 22.6% in the three months ended June 30, 2011 from 16.3% in the same period of 2010. In the six months ended June 30, 2011, cost of goods as a percentage of revenues increased to 23.0% from 19.0% in the comparable 2010 period.
Income before Income Tax
Income before income tax increased $1.26 million, or 32.1% to $5.20 million during the three months ended June 30, 2011 from $3.94 million during the same period in 2010. As a percentage of revenues, income before income tax decreased to 67.7% during the three months ended June 30, 2011 from 72.2% during the same period in 2010. For the six months ended June 30, 2011, income before income tax increased $2.07 million, or 29.2%, to $9.15 million from $7.08 million incurred in the comparable 2010 period. Income before income tax as a percentage of revenues decreased to 67.9% in the six months ended June 30, 2011 from 69.2% recorded in the same six month 2010 period. The decrease of income before income tax as a percentage of revenues is mainly attributable to the increase in costs associated with the production of our functional health beverages and an increase in selling and general and administrative expenses, which outpaced the increase in our total revenues during both the three months and six months ended June 30, 2011. The increase in selling expenses was mainly attributable to the selling and marketing expenses incurred in the rollout of our functional health beverages to additional distribution channels and costs associated with opening of the Company's specialty stores. The increase in general and administrative expenses was mainly due to increased remuneration to our management and service providers.
Net income increased by $0.49 million, or 14.2% to $3.90 million for the three months ended June 30, 2011 from $3.42 million for the same period of 2010. For the six months ended June 30, 2011, net income increased by $0.77 million, or 12.6% to $6.91 million from $6.14 million for the same period of 2010.
Earnings Per Share
Basic and diluted EPS for the three months ended June 30, 2011 was $0.26 and $0.24, based on 14.79 million and 16.39 million shares outstanding, respectively, an increase of $0.14 or 116.7% in basic EPS and $0.12 or 100% in diluted EPS from the same period in 2010 when there were approximately 14.33 million basic and 14.34 million diluted shares outstanding. For the six months ended June 30, 2011, basic and diluted EPS was $0.46 and $0.42, based on 14.64 million and 16.31 million shares outstanding, respectively, an increase of $0.15 or 48.4% in basic EPS and $0.12 or 40% in diluted EPS from the comparable 2010 period when there were roughly 14.32 million and 14.45 million shares outstanding.
As of June 30, 2011, the Company had cash and cash equivalents totaling $45.82 million, total assets of approximately $63.66 million, working capital of $45.84 million and stockholders' equity of $60.20 million. The Company generated $6.0 million in net cash from operating activities for the six months ended June 30, 2011.
For the year ending December 31, 2011, based on management's current expectations, the Company maintains its revenue guidance given at the beginning of the year.
Nutrastar will host a conference call at 8:30 a.m. ET today, Friday, August 12, 2011, to discuss the Company's second quarter 2011 financial results. Ms. Lianyun Han, Chief Executive Officer, and Mr. Robert Tick, Chief Financial Officer, will be hosting the call.
Investors are invited to participate on the live call by dialing +1 (877) 407-9039 for domestic investors. International investors can dial +1 (201) 689-8470. For investors that would like to listen to the webcast, please visit log on to http://viavid.net/dce.aspx?sid=00008B17 approximately 5 minutes before the start of the call. Please reference event ID: 376963.
If you are unable to participate in the call at this time, a replay of the call will be available for two weeks following the call starting at 11:30 a.m. ET today, August 12, 2011 and ending at 11:59 p.m. ET on August 26, 2011. To list to the replay, domestic investors can dial +1 (877) 870-5176 and International investors can dial +1 (858) 384-5517. The pass code for the replay is: 376963.
For more information regarding Nutrastar's financial performance during the three months ended June 30, 2011, please refer to the Quarterly Report on Form 10-Q to be filed with the Securities and Exchange Commission today, August 12, 2011.
About Nutrastar International Inc.Nutrastar is a China based leading producer and supplier of premium branded TCM consumer products including commercially cultivated Chinese Golden Grass ("Cordyceps Militaris") and functional health beverages. Cordyceps Militaris is one of the most highly regarded herbal nutrients in TCM. The Company is headquartered in Harbin, capital of Heilongjiang Province, with 321 employees, 21 in R&D, and 140 in sales and marketing. The products of Nutrastar are sold throughout China via a direct and distribution network that covers more than 10 provinces. More information may be found at http://www.nutrastarintl.com/ or e-mail: firstname.lastname@example.org
Make sure you are first to receive timely up-to-date information on Nutrastar. Sign up for Nutrastar's email news alert system today at: http://www.nutrastarintl.com/alerts
Safe Harbor StatementThis news release contains "forward-looking statements" relating to the business of Nutrastar and its affiliate companies. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These forward-looking statements are often identified by the use of forward-looking terminologies such as "believes," "expects" or similar expressions. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the Company with the Securities and Exchange Commission. All forward-looking statements attributable to the Company or persons acting on its behalf are expressly qualified in their entirety by these factors. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Other than as required under the securities laws, the Company does not assume a duty to update any forward-looking statements to reflect events or circumstances after the date hereof.For more information, please contact:Robert Tick, CFONutrastar International Inc.Email: email@example.comHoward GostfrandAmerican Capital VenturesTel: +1-305-918-7000Email: firstname.lastname@example.orgNUTRASTAR INTERNATIONAL INC. and subsidiariesCONDENSED CONSOLIDATED BALANCE SHEETS(AMOUNTS EXPRESSED IN US DOLLARS)June 30,December 31,20112010(Unaudited)ASSETSCURRENT ASSETSCash and cash equivalents
40,758,848Restricted cash100,260193,075Accounts receivable241,953261,223Inventories2,050,481867,761Prepayments and other receivables1,109,743289,502Total current assets49,319,32142,370,409OTHER ASSETSIntangible assets, net 2,203,0912,379,435Property, plant and equipment, net12,139,15710,248,989Total assets$63,661,569$54,998,833LIABILITIES AND STOCKHOLDERS' EQUITYCURRENT LIABILITIESAccounts payable
125,843Other payables and accruals807,026746,643Taxes payable1,899,120696,519Due to related parties52,53751,339Preferred stock dividend payable322,595181,181Warrant liabilities369,1481,198,273Total current liabilities3,465,1832,999,798Total liabilities3,465,1832,999,798COMMITMENTS AND CONTINGENCIES STOCKHOLDERS' EQUITYPreferred Stock, $0.001 par value, (1,000,000 shares authorized,151,037 shares and 197,706 shares issued and outstanding, respectively; aggregate liquidation preference amount: $4,229,036and $5,535,768, plus accrued but unpaid dividend of $322,595 and$181,181, at June 30, 2011 and December 31, 2010, respectively3,444,5734,508,914Common stock, $0.001 par value, 190,000,000 shares authorized,14,893,061and 14,332,731 shares issued and outstanding atJune 30, 2011 and December 31, 2010, respectively14,89414,333Additional paid-in capital16,866,59715,541,207Statutory reserves1,351,7441,348,071Retained earnings35,032,23328,326,896Accumulated other comprehensive income3,486,3452,259,614Total stockholders' equity60,196,38651,999,035Total liabilities and stockholders' equity $63,661,569$54,998,833NUTRASTAR INTERNATIONAL INC. and subsidiariesCONDENSED CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME(Unaudited)(AMOUNTS EXPRESSED IN US DOLLARS)For the Three MonthsFor the Six MonthsEnded June 30,Ended June 30,2011201020112010NET REVENUE
10,226,547Cost of goods sold (1,736,616)(888,415)(3,106,416)(1,944,930)Gross profit 5,946,6754,569,73710,373,1178,281,617Selling expenses (463,938)(233,310)(873,811)(405,028)General and administrative expenses (814,091)(547,331)(1,335,417)(977,117)Income from operations 4,668,6463,789,0968,163,8896,899,472Other income (expenses): Interest income 66,76633,719106,59566,796Foreign exchange differences28,864(15,698)51,785(15,269)Change in fair value of warrants 436,934131,088829,125131,088Total other income 532,564149,109987,505182,615Income before income taxes 5,201,2103,938,2059,151,3947,082,087Provision for income taxes (1,299,593)(522,564)(2,242,006)(945,384)Net income 3,901,6173,415,6416,909,3886,136,703Other comprehensive income: Foreign currency translation adjustments 714,722169,2291,226,731178,087Comprehensive income
6,314,790Earnings per share: Basic
0.30Weighted average number of shares outstanding: Basic 14,793,77514,332,73114,639,46414,322,786Diluted 16,394,90214,342,16816,309,91114,445,374NUTRASTAR INTERNATIONAL INC. and subsidiariesCONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS(Unaudited)(AMOUNTS EXPRESSED IN US DOLLARS)For the Six Months EndedJune 30,20112010CASH FLOWS FROM OPERATING ACTIVITIES:Net income
6,136,703Adjustments to reconcile net income to cash provided by operating activities:Change in fair value of warrants(829,125)(131,088)IR warrants and consultant restricted stock expense41,526-Depreciation and amortization546,552506,125Share-based compensation expense181,571105,875(Increase) decrease in assets:Accounts receivable 25,099(62,578)Prepayments and other receivables(828,948)41,662Inventories(1,150,108)(84,617)Increase (decrease) in liabilities:Accounts payable(112,813)54,073Other payables and accruals44,378(75,431)Taxes payable1,173,734(80,193)Net cash provided by operating activities6,001,2546,410,531CASH FLOWS FROM INVESTING ACTIVITIES:Purchase of property, plant and equipment(1,950,448)(8,246)Net cash used in investing activities(1,950,448)(8,246)CASH FLOWS FROM FINANCING ACTIVITIES:Proceeds from private placement-5,483,919Decrease (increase) in restricted cash92,815(350,000)Advance from related party-436,047Net cash provided by financing activities92,8155,569,966Foreign currency translation adjustment914,415174,315INCREASE IN CASH AND CASH EQUIVALENTS5,058,03612,146,566CASH AND CASH EQUIVALENTS, at the beginning of the period40,758,84820,115,677CASH AND CASH EQUIVALENTS, at the end of the period$ 45,816,884$32,262,243NON-CASH TRANSACTIONSPreferred stock and dividend converted into common stock
-Preferred stock dividend payable322,595181,181Share-based payment – IR warrants and consultant restricted stock41,526-Share-based payments to officers and directors under equity incentive plan181,571105,875SUPPLEMENTAL DISCLOSURE INFORMATIONCash paid for income taxes
|SOURCE Nutrastar International Inc.|
Copyright©2010 PR Newswire.
All rights reserved